Biocept, Inc. announces that it has been awarded Japanese Patent No. 6081434 entitled,. The issued patent covers the use of antibodies for the capture of any target of interest from any sample type on a device surface. This includes CTCs, ...
Read More »Clinical impact of serum exosomal microRNA-21 as a clinical biomarker
Exosomes are 40-nm to 100-nm membrane vesicles that are secreted by various cells, and they play a major role in cell-cell communication. The objective of this study was to clarify the significance of the levels of microRNA in exosomes extracted ...
Read More »